Although I saw this patient some months ago, I remember his case vividly.
He was a successful executive in his late 50s, referred for a second opinion after undergoing combined cataract and vitrectomy surgery on his right eye. Before the operation, his vision was a reasonable 6/9. He was healthy and had no history of major surgeries. He had a thriving career and a loving family.
But everything changed after the operation.
When he came to my office, he was clearly distressed, though he tried to hide it. His right eye was the source of his anxiety. His best corrected visual acuity was now reduced to counting fingers.
The surgery itself, performed under subtenon anesthesia, was described as uneventful. He wore a patch overnight and seemed fine. But the next morning, when he removed the patch, he was met with a devastating surprise: he couldn't see out of his right eye.
His surgeon saw him immediately. The eye appeared normal on examination, and the retina looked healthy under the slit lamp. However, an OCT scan revealed widespread inner retinal ischemia – increased reflectivity and thickening. Further tests, including a fluorescein angiogram and a stroke work-up, did not show any other abnormalities. His surgeon was not able to give him a clear answer, which is why he found himself in my office, desperate for answers.
I immediately suspected the diagnosis, confirmed by a repeat OCT:
Day-one "patch-off" vision loss
I explained to him that this is a 1 in 1300 complication where there is retinal ischaemia after an intraocular operation. The OCT findings are distinctive. The damage is irreversible, but non-progressive, and doesn't indicate any increased risk of stroke or heart attack. I shared relevant research, including the Melbourne study and its accompanying editorial. He was grateful for the explanation and the certainty of a diagnosis. He said he would learn to cope with vision in only one eye.
While this could be dismissed as a rare, isolated incident, as a retinal specialist, I see patients referred for complex macular issues. I’ve encountered two other similar cases of day-one "patch-off" vision loss after cataract surgery under subtenon anesthesia. I even had a similar case myself, although thankfully, that patient retained good central vision (6/6) despite some retinal thinning and paracentral field defects.
Something needs to change.
The editorial I mentioned suggested a possible link between subtenon anesthesia and this devastating complication. While subtenon anesthesia is necessary for some procedures like vitrectomies, cataract surgery can be safely performed using topical anesthesia. Leading cataract surgeons like David Chang and Uday Devgan routinely perform high-volume surgeries this way.
Topical anesthesia also offers several other advantages:
Simply put, it's more technically demanding. Surgeons must operate quickly and gently, minimising trauma to the eye and managing any sudden eye movements. A high level of surgical skill is essential before making this transition.
In my opinion, surgeons should meet these criteria before switching to topical anesthesia:
"Everything should be made as simple as possible, but no simpler" - Albert Einstein
When I first explored topical anesthesia, I encountered various techniques. Some used lignocaine gel, others combined it with taping, and some even applied gel outside the eyelids. Some surgeons insisted on specific speculums or used intracameral lidocaine. None of these methods gave me the results I wanted.
Then, I consulted my friend, Associate Professor James McKelvie, a high-volume cataract surgeon in Hamilton who uses a simple topical anesthesia technique. He generously shared his knowledge, which shaped my approach.
Here’s my current protocol:
I've been offering topical anesthesia for selected patients in private practice for some time. Due to the compelling reasons outlined above, I now offer it to all cataract patients, both in private and public settings. While some surgeons avoid topical anesthesia for public hospital patients due to higher case complexity, I've had success with both groups using this protocol.
There are some relative contraindications, such as dementia, inability to follow instructions, and deafness. However, you can always start with topical anesthesia and convert to subtenon if necessary.
Book your appointment now to see Dr Sheck
Dr Sheck is a RANZCO-qualified, internationally trained ophthalmologist. He combined his initial training in New Zealand with a two-year advanced fellowship in Moorfield Eye Hospital, London. He also holds a Doctorate in Ocular Genetics from the University of Auckland and a Master of Business Administration from the University of Cambridge. He specialises in medical retina diseases (injection therapy), cataract surgery, ocular genetics, uveitis and electrodiagnostics.